Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Cytometry. Part B, Clinical Cytometry|June 23, 2022
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR-ABL1, KMT2A rearrangement, and other adult B-cell precursor acute lymphoblastic leukemiaYa-Zhe Wang, Ya-Zhen Qin, Yan Chang, et al.
Cancer Medicine|August 1, 2019
High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemiaLu Yang, Wen-Min Chen, Feng-Ting Dao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2017
Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaJing Wang, Qian Jiang, Lan-Ping Xu, et al.
Zhonghua Yi Xue Za Zhi|November 27, 2007
[Detection of JAK2V617F mutation in patients with myeloproliferative disorders with TaqMan-MGB probe]Guo-rui Ruan, Shan-shan Chen, Ling-di Li, et al.
Frontiers in Oncology|April 5, 2021
The Prognostic Significance of ZNF384 Fusions in Adult Ph-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: A Comprehensive Cohort Study From a Single Chinese CenterYa-Zhen Qin, Qian Jiang, Lan-Ping Xu, et al.
Annals of Hematology|September 8, 2019
The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemiaYa-Zhen Qin, Qian Jiang, Lan-Ping Xu, et al.
Clinical and Experimental Medicine|March 28, 2024
Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemiaLi-Xin Wu, Ming-Yue Zhao, Nan Yan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 28, 2008
[PRAME mRNA expression in newly diagnosed acute myeloid leukemia patients and its application to monitoring minimal residual disease]Ya-zhen Qin, Jin-lan Li, Hong-hu Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 11, 2005
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR]Ya-zhen Qin, Guo-rui Ruan, Yan-rong Liu, et al.
British Journal of Haematology|March 13, 2025
Monitoring the KMT2A gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantationJing Liu, Xiao-Su Zhao, Ying-Jun Chang, et al.
Pageof 17